The oncology drug developer completed a Tianda and Accuron-backed series C round that initially closed at $34m last month, bringing its overall funding to $77m.

AbbVie, Eli Lilly, Johnson & Johnson, Pfizer, IBM and WuXi PharmaTech are among the backers of a $48m series A round for life sciences startup Petra Pharma.

Neurological therapeutics developer Rodin took its overall funding to more than $30m after securing financing from Biogen and co-founder Atlas Venture.

The medical diagnostics company has achieved the final close of its series B round that was raised over three tranches from investors including biotech firm Qiagen.

C4 Therapeutics has been launched by the Dana-Farber Cancer Institute with series A funding from investors including Roche, Novartis and Kraft.

Celgene, Eli Lilly and Brace Pharma participated in a series A mezzanine financing round that will help Zymeworks advance its breast cancer drugs into clinical development.

C4 Therapeutics has been launched by the Dana-Farber Cancer Institute with series A funding from investors including Roche, Novartis and Kraft.

Immuno-oncology company NextCure, which will develop products licensed from Yale School of Medicine, has closed a series A round backed by Pfizer and Eli Lilly.

India starts looking at ways to apply modern scientific techniques to ancient medicine with a memorandum of understanding between Pondicherry University and Central Council for Research.